AKT1 and metastatic melanoma: LINC00518 and LINC00520 were each found to be independent risk factors for metastatic melanoma patient survival and the network motif UCA1/hsa-miR-125b-1/AKT1 has an 88% chance of correctly identifying a TCGA sample as metastatic melanoma [101,102,103].